Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study. [electronic resource]
Producer: 20091211Description: 1609-16 p. digitalISSN:- 1435-702X
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Humans
- Injections
- Macular Edema -- diagnosis
- Male
- Middle Aged
- Prospective Studies
- Ranibizumab
- Retina -- pathology
- Retinal Vein Occlusion -- diagnosis
- Retreatment
- Time Factors
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Vitreous Body
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.